InChI=1S/C20H30O3/c1-2-19(21)17-15-13-11-9-7-5-3-4-6-8-10-12-14-16-18-20(22)23/h4-7,10-13,15,17,19,21H,2-3,8-9,14,16,18H2,1H3,(H,22,23)/b6-4-,7-5-,12-10-,13-11-,17-15+/t19-/m0/s1 |
LRWYBGFSVUBWMO-OKIFYYRFSA-N |
C(\CCCC(O)=O)=C\C/C=C\C/C=C\C/C=C\C=C\[C@H](CC)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human blood serum metabolite
Any metabolite (endogenous or exogenous) found in human blood serum samples.
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
(via 18-HEPE )
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via HEPE )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
|
|
View more via ChEBI Ontology
(5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid
|
(18S)-hydroxy-(5Z,8Z,11Z,14Z,16E)-eicosapentaenoic acid
|
ChEBI
|
(18S)-hydroxy-(5Z,8Z,11Z,14Z,16E)-icosapentaenoic acid
|
ChEBI
|
18S-HEPE
|
LIPID MAPS
|
18S-hydroxy-5Z,8Z,11Z,14Z,16E-eicosapentaenoic acid
|
LIPID MAPS
|
21206090
|
PubMed citation
|
Europe PMC
|
25187667
|
PubMed citation
|
Europe PMC
|
|